Given the small number of studies in patients with breast cancer, further studies are needed to understand the role of PD-L1 expression on CTCs during immunotherapy and to determine the relationship between the expression of PD-L1, CTCs, and tumor tissue. The gene discussed is CD274; the disease is breast cancer.